Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
02/2004
02/17/2004US6692744 Betaglycan as an inhibin receptor and uses thereof
02/17/2004US6692735 Truncated variant of c6 beta-chemokine leukotactin-1 polypeptide consisting of specified amino acid sequence
02/17/2004CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents
02/17/2004CA2183755C Pharmaceutical preparation containing plasminogen activators
02/13/2004CA2437064A1 Storage-stable, liquid fibrinogen formulation
02/12/2004WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors
02/12/2004WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
02/12/2004WO2004013128A1 Novel substituted benzamides production and use thereof as medicaments
02/12/2004WO2004013119A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
02/12/2004WO2004013115A2 Carboxamides, production and use thereof as medicaments____
02/12/2004WO2004013109A1 Resorcinol derivative
02/12/2004WO2004013104A1 Novel tetrahydroquinoline derivatives
02/12/2004WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
02/12/2004WO2004012768A1 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and/or a mtor inhibitor
02/12/2004WO2004012765A1 Medicinal agent and method for curing pathological syndrome associated to hemodiscrasia
02/12/2004WO2004012741A1 Sustained release formulations comprising lamotrigine
02/12/2004WO2004012729A1 Use of angelicin and of its structural analogues for the treatment of thalassemia
02/12/2004WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof
02/12/2004WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof
02/12/2004WO2003097582A3 Synthesis of benzonitriles and benzimidates
02/12/2004WO2003091414A3 Adipocyte complement related protein zacrp8
02/12/2004WO2003090672A3 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
02/12/2004WO2003059264A3 Methods for the induction of professional and cytokine-producing regulatory cells
02/12/2004WO2003031589A8 Peptides and related compounds having thrombopoietic activity
02/12/2004WO2003013424A3 Use of r-nsaid compounds for anti-hiv treatment
02/12/2004WO2003011213A3 Method for treating diabetes and obesity
02/12/2004WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
02/12/2004WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
02/12/2004WO2002074346A3 Targeting chemical compounds to cells
02/12/2004WO2002057454A3 Receptors and membrane-associated proteins
02/12/2004WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
02/12/2004WO2002053580A3 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
02/12/2004US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them
02/12/2004US20040029993 E-ptfe foil impregnated with an encapsulated bioative substance
02/12/2004US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
02/12/2004US20040029950 Nervous system and psychological disorders
02/12/2004US20040029938 Medicaments
02/12/2004US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/12/2004US20040029917 Benzosuberonylpiperdine compounds as analgesics
02/12/2004US20040029899 Novel compounds
02/12/2004US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders
02/12/2004US20040029880 Anthranyl amides and their use as medicaments
02/12/2004US20040029874 Anticoagulants; cardiovascular disorders
02/12/2004US20040029866 Polymerase enzyme inhibitors
02/12/2004US20040029853 Therapy for gastrointestinal disorders
02/12/2004US20040029847 Anticancer agents; contraceptives
02/12/2004US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor
02/12/2004US20040029803 Binding to apoptosis cells
02/12/2004US20040029799 Medicament containing activated antithrombin III
02/12/2004US20040029782 Antiinflammatory agents; osteoporosis; cardiovascular disorders; coating for prosthetics
02/12/2004US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes
02/12/2004US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body
02/12/2004US20040029247 Regulation of human adenylate cyclase, type iv
02/12/2004US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/12/2004US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders
02/12/2004US20040028684 Cancer diagnosis and assays for screening anti-cancer agents
02/12/2004US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes
02/12/2004US20040028658 Methods of organ regeneration
02/12/2004US20040028649 Regenerating cells
02/12/2004DE10233412A1 Neue Verbindungen als Histondeacetylase-Inhibitoren New connections as histone deacetylase inhibitors
02/12/2004CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs
02/12/2004CA2494146A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
02/12/2004CA2494114A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
02/12/2004CA2493301A1 Sustained release formulations comprising lamotrigine
02/11/2004EP1388344A1 Composition comprising Salvia Miltiorrhizae, Ginseng, Borneol for treating heart disease, and cerebrovascular diseases
02/11/2004EP1388342A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
02/11/2004EP1388341A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
02/11/2004EP1387889A2 Kinases and phosphatases
02/11/2004EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
02/11/2004EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
02/11/2004EP1387691A1 Blood coagulation factor xiii for treating platelet disorders
02/11/2004EP1387688A2 Benzazepinone alpha v integrin receptor antagonists
02/11/2004EP1387680A1 Benzimidazole derivatives as therapeutic agents
02/11/2004EP1387679A1 Sulfonamides
02/11/2004EP1235569B1 Medicament and combination of compatible medicaments
02/11/2004EP1231908B1 Pharmaceutical composition comprising a no donor compound and its use
02/11/2004EP1107776B1 Dry extract of henna, method for producing said extract and use of the same
02/11/2004EP0994716B1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body
02/11/2004CN1474816A 4-amino-quinazolines
02/11/2004CN1474815A 4-amino-quinazolines
02/11/2004CN1474813A Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists
02/11/2004CN1474702A Oral pharmaceutical composition containing a block copolymer
02/11/2004CN1474690A Synergestic combinations comprising renin inhibitor for cardiovascular diseases
02/11/2004CN1474688A Novel uses of combined selective dopamine D2 receptor antagonists and 5-HT1A receptor agonists
02/11/2004CN1473622A New use of combined monoclonal antibody in treating acute local hydrops caused by injury
02/11/2004CN1473608A Chinese medicine preparation for treating blood viscosity symdrome and its preparing method
02/11/2004CN1137688C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
02/10/2004US6689906 Bicyclic amino acids as pharmaceutical agents
02/10/2004US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same
02/10/2004US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity
02/10/2004US6689804 Imidazo-imidazole
02/10/2004US6689794 Aromatic sulfone hydroxamates and their use as protease inhibitors
02/10/2004US6689786 Sulfonylurea, sulfonylthiourea, sulfonylguanidine, sulfonylcyanoguanidine and acylsulfonamide derivatives; antithrombotics
02/10/2004US6689780 Heteroroaromatic amides as inhibitor of factor Xa
02/10/2004US6689778 2-phenylamino-5-isoxazo-4-yl-pyrimidine derivatives
02/10/2004US6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-α, and aggrecanase
02/10/2004US6689393 Glucose concentration can be varied without influencing the concentration of the other components; three individual solutions are combined and administered after heat sterilization; calcium ions, electrolyte salts, and a buffer
02/10/2004US6689350 Therapeutic polyesters and polyamides
02/10/2004CA2231026C Novel derivatives of benzenesulfonylamine, process for their preparation and pharmaceutical compositions containing them
02/10/2004CA2106474C Polyoxypropylene/polyoxyethylene copolymers with improved biological activity